You are here : Home / Quarterly Results / GLAND PHARMA LTD

GLAND PHARMA Quarterly Results Analysis Q2FY22 [Sep2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 22-Oct-21 Details👇

GLAND PHARMA Quarterly Results

Consolidated Sep2021
UnAudited
Jun2021
UnAudited
Mar2021
Audited
Sep2020
UnAudited
Jun2020
UnAudited
Mar2020
Audited
Revenues ₹1,080 Cr ₹1,154 Cr ₹888 Cr ₹832 Cr ₹884 Cr ₹635 Cr
Expenses ₹704 Cr ₹718 Cr ₹560 Cr ₹534 Cr ₹472 Cr ₹395 Cr
Operating Income ₹377 Cr ₹436 Cr ₹328 Cr ₹298 Cr ₹413 Cr ₹240 Cr
Other Income ₹51 Cr ₹62 Cr ₹47 Cr ₹20 Cr ₹32 Cr ₹46 Cr
Interest ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹0 Cr
Depreciation ₹26 Cr ₹25 Cr ₹25 Cr ₹25 Cr ₹24 Cr ₹24 Cr
Profit Before Tax ₹401 Cr ₹472 Cr ₹349 Cr ₹293 Cr ₹420 Cr ₹262 Cr
Profit After Tax ₹302 Cr ₹351 Cr ₹260 Cr ₹219 Cr ₹314 Cr ₹195 Cr
EPS ₹18.39 ₹21.39 ₹15.92 ₹14.12 ₹20.24 ₹12.57

Check out Industry Peers

Peers & Returns1W1M1Y
GLAND PHARMA -1.5% -4.6% NA
SUN PHARMACEUTICAL INDUSTRIES -2.7% 5.6% 69.1%
DIVIS LABORATORIES -4.8% -1.2% 67.8%
DR REDDYS LABORATORIES -4.9% -4.4% -8%
CIPLA -0.9% -7.1% 19.3%
PIRAMAL ENTERPRISES -8.1% -2% 102.9%
CADILA HEALTHCARE -6% -10.5% 20.8%
TORRENT PHARMACEUTICALS -4.6% -3.9% 12.5%
ALKEM LABORATORIES -3% -3.7% 42.9%

GLAND PHARMA Quarterly Revenues

Revenues
Q-o-Q

-6.36 %

Y-o-Y

22.20 %

Quarters Revenues % Change
Sep2021 ₹1,080 Cr
-6.36
Jun2021 ₹1,154 Cr
29.98
Mar2021 ₹888 Cr
6.76
Sep2020 ₹832 Cr
-5.96
Jun2020 ₹884 Cr
39.19
Mar2020 ₹635 Cr -

GLAND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-13.68 %

Y-o-Y

-8.73 %

Quarters Operating Profit % Change
Sep2021 ₹377 Cr
-13.68
Jun2021 ₹436 Cr
33.15
Mar2021 ₹328 Cr
10.07
Sep2020 ₹298 Cr
-27.85
Jun2020 ₹413 Cr
72.02
Mar2020 ₹240 Cr -
Operating Margins
Q-o-Q

-7.80 %

Y-o-Y

-25.31 %

Quarters Operating Margin% % Change
Sep2021 34.86%
-7.80
Jun2021 37.81%
2.44
Mar2021 36.91%
3.10
Sep2020 35.8%
-23.29
Jun2020 46.67%
23.60
Mar2020 37.76% -

GLAND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-13.85 %

Y-o-Y

-3.67 %

Quarters Profit After Tax % Change
Sep2021 ₹302 Cr
-13.85
Jun2021 ₹351 Cr
34.65
Mar2021 ₹260 Cr
18.99
Sep2020 ₹219 Cr
-30.21
Jun2020 ₹314 Cr
60.99
Mar2020 ₹195 Cr -
PAT Margins
Q-o-Q

-8.00 %

Y-o-Y

-21.17 %

Quarters PAT Margin(%) % Change
Sep2021 27.96 %
-8.00
Jun2021 30.39 %
3.61
Mar2021 29.33 %
11.44
Sep2020 26.32 %
-25.80
Jun2020 35.47 %
15.69
Mar2020 30.66 % -

GLAND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-14.03 %

Y-o-Y

-9.14 %

Quarters EPS % Change
Sep2021 ₹18.39
-14.03
Jun2021 ₹21.39
34.36
Mar2021 ₹15.92
12.75
Sep2020 ₹14.12
-30.24
Jun2020 ₹20.24
61.02
Mar2020 ₹12.57 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

GLAND PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE 100 LARGECAP TMC -2.4% 2.8% 55.6%
S&P BSE LARGE MIDCAP -2.7% 2.9% 57.9%
S&P BSE 200 -2.7% 2.8% 58.9%
S&P BSE 250 LARGEMIDCAP -2.9% 2.7% 59.4%
S&P BSE 500 -3.1% 2.7% 61.2%
S&P BSE ALLCAP -3.2% 2.7% 62.3%
S&P BSE HEALTHCARE -4.4% -5% 27.9%
S&P BSE IPO -4.9% 0.7% 96.3%
S&P BSE MID CAP -5.1% 1.6% 76.6%
S&P BSE MIDSMALLCAP -5.5% 1.7% 85.5%
NSE Indices1W1M1Y
NIFTY 100 -2.4% 2.6% 55.1%
NIFTY LARGE MIDCAP 250 -2.4% 4.3% 70.8%
NIFTY 200 -2.8% 2.8% 58.7%
NIFTY 500 -3.1% 2.7% 60.9%
NIFTY NEXT 50 -5.2% -1.3% 58.4%

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z